NDC 0069-0253

Fragmin

Dalteparin Sodium

Fragmin is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Dalteparin Sodium.

• Product ID: 0069-0253_ac17f7ce-f87e-4ad9-8dff-743e82ea16ca
• NDC: 0069-0253
• Product Type: Human Prescription Drug
• Proprietary Name: Fragmin
• Generic Name: Dalteparin Sodium
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2022-10-17
• Marketing Category: NDA /
• Application Number: NDA020287
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: DALTEPARIN SODIUM
• Active Ingredient Strength: 2500 [iU]/mL
• Pharm Classes: Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0069-0253-10

10 VIAL, SINGLE-DOSE in 1 CARTON (0069-0253-10) > 4 mL in 1 VIAL, SINGLE-DOSE (0069-0253-01)

• Marketing Start Date: 2022-10-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Fragmin" or generic name "Dalteparin Sodium"

NDC	Brand Name	Generic Name
0069-0195	Fragmin	Dalteparin Sodium
0069-0196	Fragmin	Dalteparin Sodium
0069-0206	Fragmin	Dalteparin Sodium
0069-0217	Fragmin	Dalteparin Sodium
0069-0220	Fragmin	Dalteparin Sodium
0069-0223	Fragmin	Fragmin
0069-0228	Fragmin	Fragmin
0069-0232	Fragmin	Fragmin